Yüklüyor......
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
BACKGROUND & AIMS: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening or procedures has been interrupted or delayed b...
Kaydedildi:
| Yayımlandı: | JHEP Rep |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7901294/ https://ncbi.nlm.nih.gov/pubmed/33644725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100260 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|